Start › Nowotwory (wszystkie typy) › Michigan › Grand Rapids
Badania kliniczne dla Nowotwory (wszystkie typy) w mieście Grand Rapids, MI
28 badań dla Nowotwory (wszystkie typy) szuka uczestników w ośrodkach w mieście Grand Rapids i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
RekrutacjaFaza 2
- START Midwest ( Site 1103), Grand Rapids
REC-7735 in Participants With Solid Tumors
RekrutacjaFaza 1/2
- START Midwest, Grand Rapids
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
RekrutacjaFaza 1
- START Midwest /ID# 279035, Grand Rapids
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
RekrutacjaFaza 1/2
- Corewell Health ( Site 4001), Grand Rapids
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
RekrutacjaFaza 1
- Start Midwest, Grand Rapids
A Study of JNJ-87890387 for Advanced Solid Tumors
RekrutacjaFaza 1
- Start Midwest, Grand Rapids
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RekrutacjaFaza 3
- Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279955, Grand Rapids
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekrutacjaFaza 2
- Cancer Research Consortium of West Michigan, Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekrutacjaFaza 1/2
- START Midwest, Grand Rapids
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
RekrutacjaFaza 1/2
- Corewell Health ( Site 3001), Grand Rapids
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekrutacjaFaza 1
- START - Midwest Cancer Research Center, Grand Rapids
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekrutacjaFaza 3
- The Cancer & Hematology Centers, Grand Rapids
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
RekrutacjaFaza 3
- Cancer and Hematology Centers of Western Michigan, Grand Rapids
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
RekrutacjaFaza 1
- START Midwest, Grand Rapids
Project: Every Child for Younger Patients With Cancer
RekrutacjaBadanie obserwacyjne
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
RekrutacjaFaza 1/2
- Site 04, Grand Rapids
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
RekrutacjaFaza 1
- START Midwest, Grand Rapids
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
RekrutacjaFaza 1
- START Midwest, Grand Rapids
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekrutacjaFaza 3
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
RekrutacjaFaza 1Zapraszamy zdrowych ochotników
- BAMF Health Inc., Grand Rapids
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekrutacjaFaza 1/2
- START Midwest, Grand Rapids
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
RekrutacjaFaza 1/2
- START Midwest, Grand Rapids
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
RekrutacjaFaza 1
- GSK Investigational Site, Grand Rapids
CT-95 in Advanced Cancers Associated With Mesothelin Expression
RekrutacjaFaza 1
- Context Investigational Site, Grand Rapids
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
RekrutacjaFaza 1
- START Midwest, Grand Rapids
A Study of YL242 in Subjects With Advanced Solid Tumors
RekrutacjaFaza 1/2
- US-206, Grand Rapids
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
RekrutacjaBadanie obserwacyjne
- Corewell Health, Grand Rapids
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Rekrutacja
- Mercy Health Saint Mary's, Grand Rapids
- Spectrum Health at Butterworth Campus, Grand Rapids
Badania dla Nowotwory (wszystkie typy) w innych miastach
- Houston, TX121 badań
- New York City, NY109 badań
- Boston, MA85 badań
- Los Angeles, CA74 badań
- Nashville, TN65 badań
- Philadelphia, PA59 badań
- Washington, DC58 badań
- Durham, NC58 badań
- Chicago, IL51 badań
- Atlanta, GA49 badań
- Seattle, WA49 badań
- Arlington, VA48 badań
Inne badania w mieście Grand Rapids
- Niedrobnokomórkowy rak płuca44 badań
- Rak jelita grubego i odbytnicy40 badań
- Rak piersi26 badań
- Rak jajnika24 badań
- Nowotwór przerzutowy22 badań
- Rak prostaty19 badań
- Rak endometrium18 badań
- Nowotwór żołądka18 badań
- Rak trzustki18 badań
- Czerniak17 badań
- Rak płaskonabłonkowy głowy i szyi15 badań
- Rak piersi potrójnie ujemny15 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.